Shots:
- Miach Orthopaedics has completed enrollment in the BEAR MOON study of BEAR Implant for the treatment of anterior cruciate ligament (ACL) tears
- BEAR MOON trial, led by Cleveland Clinic, enrolled 150 pts (18–55yrs.) with complete ACL tears, randomized to receive either the BEAR Implant or autograft bone-patellar tendon-bone ACL reconstruction, with outcomes assessed at 6mos., 1yr., & 2yrs. post surgery. Data will be presented & published after 2yr. of follow-up
- BEAR (Bridge-Enhanced ACL Restoration) is a collagen-based implant that promotes ACL healing by bridging torn ends, thereby, preventing the need for tendon grafts or additional surgical sites required in standard ACL reconstruction
Ref: Businesswire | Image: Miach Orthopaedics | Press Release
Related News:- Apogee Therapeutics Reports P-II (APEX) Trial Data on APG777 for Atopic Dermatitis (AD)
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
